Shudao Xiong

6PUBLICATIONS
10CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 11, 2024
HDAC2-miR183-5p epigenetic circuit contributes to the growth of Philadelphia chromosome-positive B cell acute lymphoblastic leukemia via PTEN/AKT and c-MYC signaling pathway.

Yangyang Ding, Xiangjiang Feng, Zelin Liu

|Jul 03, 2024
Rapid identification of early infections in febrile patients after CD19 target CAR-T cell therapy for B-cell malignancies.

Lian-Fang Pu, Hui-Min Zheng, Xiang-Jiang Feng

|Mar 20, 2024
The CDK4/6 Inhibitor Palbociclib Synergizes with ATRA to Induce Differentiation in AML.

Linhui Hu, Qian Li, Jiyu Wang

|Jun 29, 2023
Prognostic value of soluble programmed cell death ligand-1 (sPD-L1) in lymphoma: a systematic review and meta-analysis.

Yangyang Ding, Cheng Sun, Linhui Hu

|Nov 13, 2019
Red blood cell distribution width and platelet counts are independent prognostic factors and improve the predictive ability of IPI score in diffuse large B-cell lymphoma patients.

Manman Li, Hailong Xia, Huimin Zheng

|Sep 21, 2017
The Prognostic Significance of Soluble Programmed Death Ligand 1 Expression in Cancers: A Systematic Review and Meta-analysis.

Y Ding, C Sun, J Li

Pageof 1

Frequent Collaborators

1 joint publications

Linhui Hu

1 joint publications

Qian Li

1 joint publications

Jiyu Wang

1 joint publications

Huiping Wang